DataMeds AI, Inc. Operating Expenses
DataMeds AI, Inc. (MEDS) reported Operating Expenses of $7.53 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-17
- DataMeds AI, Inc. operating expenses for the quarter ending 2026-06-30 was $7.53M, a 25.33% increase year-over-year.
- DataMeds AI, Inc. operating expenses for the quarter ending 2026-03-31 was $6.19M, a 80.69% decline year-over-year.
- DataMeds AI, Inc. operating expenses for the quarter ending 2025-12-31 was $17.50M, a 250.19% increase year-over-year.
- DataMeds AI, Inc. operating expenses for the quarter ending 2025-09-30 was $31.78M, a 1302.40% increase year-over-year.
- DataMeds AI, Inc. operating expenses for fiscal 2025 was $87.32M, a 1003.61% increase from fiscal 2024.
- DataMeds AI, Inc. operating expenses for fiscal 2024 was $7.91M, a 174.68% increase from fiscal 2023.
- DataMeds AI, Inc. operating expenses for fiscal 2023 was $2.88M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.53M 10-Q · filed 2026-08-17 | $13.71M 10-Q · filed 2026-08-17 | $31.21M derived: sum of 3 quarters · filed 2026-08-17 | $62.99M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $6.19M 10-Q · filed 2026-05-19 | $23.68M derived: sum of 2 quarters · filed 2026-05-19 | $55.46M derived: sum of 3 quarters · filed 2026-05-19 | $61.47M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $17.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $49.28M derived: sum of 2 quarters · filed 2026-03-20 | $55.28M derived: sum of 3 quarters · filed 2026-08-17 | $87.32M 10-K · filed 2026-03-20 |
| 2025-09-30 | $31.78M 10-Q · filed 2025-11-19 | $37.79M derived: sum of 2 quarters · filed 2026-08-17 | $69.83M 10-Q · filed 2025-11-19 | $74.82M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $6.01M 10-Q · filed 2026-08-17 | $38.05M 10-Q · filed 2026-08-17 | $43.04M derived: sum of 3 quarters · filed 2026-08-17 | $45.31M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $32.04M 10-Q · filed 2026-05-19 | $37.04M derived: sum of 2 quarters · filed 2026-05-19 | $39.30M derived: sum of 3 quarters · filed 2026-05-19 | $39.87M derived: sum of 4 quarters · filed 2026-05-19 |
| 2024-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $7.26M derived: sum of 2 quarters · filed 2026-03-20 | $7.83M derived: sum of 3 quarters · filed 2026-03-20 | $7.91M 10-K · filed 2026-03-20 |
| 2024-09-30 | $2.27M 10-Q · filed 2025-11-19 | $2.84M derived: sum of 2 quarters · filed 2025-11-19 | $2.92M 10-Q · filed 2025-11-19 | |
| 2024-06-30 | $570.41K 10-Q · filed 2025-08-19 | $650.17K 10-Q · filed 2025-08-19 | ||
| 2024-03-31 | $79.76K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $2.88M 10-K · filed 2025-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |